Regenerative medicine company AVITA Medical (ASX:AVH) has won the Australasian Investor Relations Association (AIRA) Award for Best Investor Relations by a company in the S&P/ASX Emerging Companies Index.
AIRA’s Best Practice Investor Relations Awards recognise industry leaders for their efforts in working openly and effectively with the professional investment community. Winners are determined by an independent survey of domestic and international buy and sell-side brokers and fund managers.
AVITA chief financial officer Michael Holder said, “We thank AIRA for its continued support for this award which recognises the significance of imparting our strategy, performance and, critically, the potential of our company to the investment community.”
The AIRA investor relations awards are considered to be the most prestigious investor relations awards in Australia and are sponsored by the Australian Securities Exchange.